US Stock MarketDetailed Quotes

CNBX Pharmaceuticals (CNBX)

Watchlist
  • 0.0002
  • 0.00000.00%
15min DelayClose May 18 15:52 ET
245.15KMarket Cap0.20P/E (TTM)

CNBX Pharmaceuticals (CNBX) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Feb 28, 2026
(Q1)Nov 30, 2025
(FY)Aug 31, 2025
(Q4)Aug 31, 2025
(Q3)May 31, 2025
(Q2)Feb 28, 2025
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
-73.39%12.15K
-55.57%7.7K
-42.80%15.11K
-42.80%15.11K
-81.41%13.65K
22.97%45.68K
-78.76%17.34K
-79.63%26.42K
-79.63%26.42K
66.26%73.41K
-Cash and cash equivalents
-73.39%12.15K
-55.57%7.7K
-42.80%15.11K
-42.80%15.11K
-81.41%13.65K
22.97%45.68K
-78.76%17.34K
-79.63%26.42K
-79.63%26.42K
66.26%73.41K
Receivables
-44.93%2.75K
-30.39%3.46K
-33.04%3.33K
-33.04%3.33K
-24.98%4.97K
-96.07%4.99K
-92.83%4.97K
-94.75%4.97K
-94.75%4.97K
-97.83%6.62K
-Other receivables
-44.93%2.75K
-30.39%3.46K
-33.04%3.33K
-33.04%3.33K
-24.98%4.97K
-96.07%4.99K
-92.83%4.97K
-94.75%4.97K
-94.75%4.97K
-97.83%6.62K
Total current assets
-70.59%14.9K
-49.96%11.16K
-41.25%18.44K
-41.25%18.44K
-76.74%18.62K
-69.09%50.66K
-85.22%22.31K
-86.01%31.38K
-86.01%31.38K
-77.06%80.03K
Non current assets
Net PPE
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Investments and advances
----
----
----
----
----
----
----
--0
--0
----
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-70.59%14.9K
-49.96%11.16K
-41.25%18.44K
-41.25%18.44K
-76.74%18.62K
-69.09%50.66K
-94.24%22.31K
-93.71%31.38K
-93.71%31.38K
-87.91%80.03K
Liabilities
Current liabilities
Payables
13.15%1.38M
10.69%1.34M
8.32%1.32M
8.32%1.32M
-1.99%1.22M
-0.61%1.22M
3.44%1.21M
3.71%1.22M
3.71%1.22M
0.13%1.24M
-accounts payable
-30.84%43.53K
-12.23%45.63K
20.59%49.25K
20.59%49.25K
-78.27%41.24K
-72.80%62.94K
-78.84%51.99K
-87.84%40.84K
-87.84%40.84K
-81.30%189.82K
-Due to related parties current
15.54%1.34M
11.72%1.29M
7.90%1.27M
7.90%1.27M
11.79%1.17M
16.12%1.16M
25.36%1.16M
40.46%1.18M
40.46%1.18M
369.82%1.05M
Current debt and capital lease obligation
-16.69%1.17M
-6.15%1.25M
-7.56%1.2M
-7.56%1.2M
3.58%1.34M
8.22%1.4M
1.07%1.33M
-3.61%1.3M
-3.61%1.3M
-2.91%1.29M
-Current debt
-16.69%1.17M
-6.15%1.25M
-7.56%1.2M
-7.56%1.2M
3.58%1.34M
8.22%1.4M
1.07%1.33M
-3.61%1.3M
-3.61%1.3M
-2.91%1.29M
Current liabilities
-2.77%2.55M
1.87%2.58M
0.13%2.51M
0.13%2.51M
0.85%2.56M
3.91%2.62M
2.19%2.54M
-0.20%2.51M
-0.20%2.51M
-1.44%2.53M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-2.77%2.55M
1.87%2.58M
0.13%2.51M
0.13%2.51M
0.85%2.56M
3.91%2.62M
2.19%2.54M
-0.20%2.51M
-0.20%2.51M
-1.44%2.53M
Shareholders'equity
Share capital
3,224.78%112.58K
2,321.05%75.32K
1,680.65%55.4K
1,680.65%55.4K
197.36%9.25K
8.84%3.39K
9.89%3.11K
37.59%3.11K
37.59%3.11K
94.07%3.11K
-common stock
3,224.78%112.58K
2,321.05%75.32K
1,680.65%55.4K
1,680.65%55.4K
197.36%9.25K
8.84%3.39K
9.89%3.11K
37.59%3.11K
37.59%3.11K
94.07%3.11K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-1.47%-25.43M
-1.57%-25.38M
-1.26%-25.27M
-1.26%-25.27M
-0.90%-25.12M
-1.19%-25.06M
-2.25%-24.99M
-2.87%-24.95M
-2.87%-24.95M
-5.10%-24.89M
Paid-in capital
1.31%22.78M
1.17%22.73M
1.09%22.72M
1.09%22.72M
0.60%22.57M
0.37%22.48M
0.59%22.47M
1.04%22.47M
1.04%22.47M
20.33%22.44M
Gains losses not affecting retained earnings
--0
----
----
----
--0
--0
--0
--0
--0
----
Total stockholders'equity
1.44%-2.53M
-2.33%-2.57M
-0.66%-2.5M
-0.66%-2.5M
-3.38%-2.54M
-8.99%-2.57M
-20.02%-2.51M
-22.94%-2.48M
-22.94%-2.48M
-28.54%-2.45M
Total equity
1.44%-2.53M
-2.33%-2.57M
-0.66%-2.5M
-0.66%-2.5M
-3.38%-2.54M
-8.99%-2.57M
-20.02%-2.51M
-22.94%-2.48M
-22.94%-2.48M
-28.54%-2.45M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Feb 28, 2026(Q1)Nov 30, 2025(FY)Aug 31, 2025(Q4)Aug 31, 2025(Q3)May 31, 2025(Q2)Feb 28, 2025(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments -73.39%12.15K-55.57%7.7K-42.80%15.11K-42.80%15.11K-81.41%13.65K22.97%45.68K-78.76%17.34K-79.63%26.42K-79.63%26.42K66.26%73.41K
-Cash and cash equivalents -73.39%12.15K-55.57%7.7K-42.80%15.11K-42.80%15.11K-81.41%13.65K22.97%45.68K-78.76%17.34K-79.63%26.42K-79.63%26.42K66.26%73.41K
Receivables -44.93%2.75K-30.39%3.46K-33.04%3.33K-33.04%3.33K-24.98%4.97K-96.07%4.99K-92.83%4.97K-94.75%4.97K-94.75%4.97K-97.83%6.62K
-Other receivables -44.93%2.75K-30.39%3.46K-33.04%3.33K-33.04%3.33K-24.98%4.97K-96.07%4.99K-92.83%4.97K-94.75%4.97K-94.75%4.97K-97.83%6.62K
Total current assets -70.59%14.9K-49.96%11.16K-41.25%18.44K-41.25%18.44K-76.74%18.62K-69.09%50.66K-85.22%22.31K-86.01%31.38K-86.01%31.38K-77.06%80.03K
Non current assets
Net PPE --0--0--0--0--0--0--0--0--0--0
Investments and advances ------------------------------0--0----
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -70.59%14.9K-49.96%11.16K-41.25%18.44K-41.25%18.44K-76.74%18.62K-69.09%50.66K-94.24%22.31K-93.71%31.38K-93.71%31.38K-87.91%80.03K
Liabilities
Current liabilities
Payables 13.15%1.38M10.69%1.34M8.32%1.32M8.32%1.32M-1.99%1.22M-0.61%1.22M3.44%1.21M3.71%1.22M3.71%1.22M0.13%1.24M
-accounts payable -30.84%43.53K-12.23%45.63K20.59%49.25K20.59%49.25K-78.27%41.24K-72.80%62.94K-78.84%51.99K-87.84%40.84K-87.84%40.84K-81.30%189.82K
-Due to related parties current 15.54%1.34M11.72%1.29M7.90%1.27M7.90%1.27M11.79%1.17M16.12%1.16M25.36%1.16M40.46%1.18M40.46%1.18M369.82%1.05M
Current debt and capital lease obligation -16.69%1.17M-6.15%1.25M-7.56%1.2M-7.56%1.2M3.58%1.34M8.22%1.4M1.07%1.33M-3.61%1.3M-3.61%1.3M-2.91%1.29M
-Current debt -16.69%1.17M-6.15%1.25M-7.56%1.2M-7.56%1.2M3.58%1.34M8.22%1.4M1.07%1.33M-3.61%1.3M-3.61%1.3M-2.91%1.29M
Current liabilities -2.77%2.55M1.87%2.58M0.13%2.51M0.13%2.51M0.85%2.56M3.91%2.62M2.19%2.54M-0.20%2.51M-0.20%2.51M-1.44%2.53M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -2.77%2.55M1.87%2.58M0.13%2.51M0.13%2.51M0.85%2.56M3.91%2.62M2.19%2.54M-0.20%2.51M-0.20%2.51M-1.44%2.53M
Shareholders'equity
Share capital 3,224.78%112.58K2,321.05%75.32K1,680.65%55.4K1,680.65%55.4K197.36%9.25K8.84%3.39K9.89%3.11K37.59%3.11K37.59%3.11K94.07%3.11K
-common stock 3,224.78%112.58K2,321.05%75.32K1,680.65%55.4K1,680.65%55.4K197.36%9.25K8.84%3.39K9.89%3.11K37.59%3.11K37.59%3.11K94.07%3.11K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -1.47%-25.43M-1.57%-25.38M-1.26%-25.27M-1.26%-25.27M-0.90%-25.12M-1.19%-25.06M-2.25%-24.99M-2.87%-24.95M-2.87%-24.95M-5.10%-24.89M
Paid-in capital 1.31%22.78M1.17%22.73M1.09%22.72M1.09%22.72M0.60%22.57M0.37%22.48M0.59%22.47M1.04%22.47M1.04%22.47M20.33%22.44M
Gains losses not affecting retained earnings --0--------------0--0--0--0--0----
Total stockholders'equity 1.44%-2.53M-2.33%-2.57M-0.66%-2.5M-0.66%-2.5M-3.38%-2.54M-8.99%-2.57M-20.02%-2.51M-22.94%-2.48M-22.94%-2.48M-28.54%-2.45M
Total equity 1.44%-2.53M-2.33%-2.57M-0.66%-2.5M-0.66%-2.5M-3.38%-2.54M-8.99%-2.57M-20.02%-2.51M-22.94%-2.48M-22.94%-2.48M-28.54%-2.45M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 18 Eastern Time, Trump temporarily halted the planned 'major' military strike on Iran, citing that Gulf allies requested room for neg Show More